openPR Logo
Press release

Cytomegalovirus Treatment Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

10-19-2023 06:41 PM CET | Health & Medicine

Press release from: Orion Market Research

Cytomegalovirus Treatment Market Share, Trends, Future

The global cytomegalovirus treatment market is anticipated to grow at a CAGR of 30.1% during the forecast period (2023-2030). Cytomegalovirus is one of the most common and serious post-transplant infections and can lead to loss of transplanted organ and failure of graft. It has a global estimated incidence rate of 16.0%-56.0% in SOT recipients and 30.0%-70.0% in HSCT recipients.More than 34,000 SOTs and more than 48,000 HSCTs were performed in Europe and neighboring countries in 2019. Thus, the growing drug approval for its treatment is a key factor driving the growth of the global cytomegalovirus treatment market.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/cytomegalovirus-treatment-market

For instance, in September 2022, Takeda announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of maribavir for the treatment of cytomegalovirus (CMV) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a hematopoietic stem cell transplant (HSCT) or solid organ transplant (SOT).
In August 2022, Florida, US-based firm Fortress Biotech has been awarded a $20 million grant to develop its cytomegalovirus vaccine Triplex. Under development by its subsidiary Helocyte, Triplex is a universal viral vector vaccine, which has been engineered to induce a cytomegalovirus -specific T cell response. In previous Phase I and Phase II studies, it has been found to be safe, well-tolerated and immunogenic. Helocyte has secured an exclusive worldwide license to Triplex from its originator, City of Hope cancer research center.Fortress plans to test its candidate across up to 15 transplant centers in the US. Triplex was developed by City of Hope, one of the largest cancer research and treatment organizations in the US. Development of cytomegalov
irus vaccine may restrain the global cytomegalovirus treatment market.

Market Coverage

• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Drug Type
o By Application
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including F. Hoffmann-La Roche Ltd, Teva Canada Ltd., Gilead Sciences, Inc., Thermo Fisher Scientific, Inc., and Merck & Co., Inc. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cytomegalovirus Treatment Market Report Segment

By Drug Type

• Cidofovir
• Foscarnet
• Valganciclovir
• Ganciclovir

By Application

• Stem Cell Transplantation
• Organ Transplantation
• Congenital CMV Infection
• Other Application
By Distribution Channel
• Hospital pharmacies
• Retail Pharmacies
• E-commerce

A full report of Cytomegalovirus Treatment Market available @ https://www.omrglobal.com/industry-reports/cytomegalovirus-treatment-market

Global Cytomegalovirus Treatment Market Report Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AiCuris Anti-infective Cures GmbH
• Chimerix, Inc.
• Clinigen Group PLC
• F. Hoffmann-La Roche AG
• Fresenius Kabi Canada
• Genentech Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Moderna, Inc.
• Mylan N.V
• Pfizer Inc.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytomegalovirus Treatment Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030 here

News-ID: 3257340 • Views:

More Releases from Orion Market Research

Earbuds Market Will Exhibit an Impressive Expansion by 2024-2031 | Apple Inc., BRAGI GmbH, Samsung Electronics, Sennheiser electronic GmbH & Co. KG
Earbuds Market Will Exhibit an Impressive Expansion by 2024-2031 | Apple Inc., B …
The global earbuds market is anticipated to grow at an exponential CAGR of 21.3% during the forecast period. One of the key driving factors fuelling the market growth includes the growing competitiveness among the market players. The demand for earbuds has been growing continuously over the past few years which has grown the number of market players as well. The market players have been offering new earbuds every few months,
Vitamin Fortified and Mineral Enriched Food and Beverage Market Increasing Demand, Growth Analysis and Future Outlook by 2031/ Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc.
Vitamin Fortified and Mineral Enriched Food and Beverage Market Increasing Deman …
The global vitamin fortified and mineral enriched food and beverage market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period. The growing awareness about nutrient deficiency such as vitamin A, D, iron, and other nutrients is boosting the global vitamin fortified and mineral enriched food and beverage market during the forecast period. According to the World Health Organization (WHO), in 2019, around 29.9% of women aged
Fortified Wine Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2031 | Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc.
Fortified Wine Market is Likely to Increase at a Significantly High CAGR during …
Fortified wine market is estimated to grow at a CAGR of nearly 4.8% during the forecast period. The major factors contributing to the growth of the market include emerging demand for premium alcoholic beverages and growing disposable income across emerging countries. As per the State Council of the People's Republic of China, the country's per capita disposable income stood at $1,265 in the first three months of 2019, up 6.8%
Fragrance Market Is Expected to Exhibit Significant Growth Over 2031 International Flavors & Fragrances Inc., Sensient Technologies Corp., Givaudan SA, Symrise AG
Fragrance Market Is Expected to Exhibit Significant Growth Over 2031 Internation …
The global fragrance market is anticipated to grow at a considerable CAGR of 4.5% during the forecast period. The growing number of Gen Z and millennials is one of the most important elements influencing the fragrance industry. Younger customers and millennials are becoming more interested in personal grooming and are willing to try new concepts and companies. With more disposable income and increased exposure to foreign lifestyle patterns, the younger generation is

All 5 Releases


More Releases for Cytomegalovirus

Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026
Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many
Cytomegalovirus Assay Market Latest Report with Forecast 2017-2027
Global Cytomegalovirus Assay Market: Snapshot CMV diagnostics turn out to be exceptionally basic for immunocompromised people and pregnant ladies as well. Cytomegaloviruses are one of the main sources of mental hindrance in kids and viral diseases. A cytomegalovirus can cause asymptomatic contaminations in immunocompromised people and can be transmitted to the embryo while pregnancy from his mom, which may show essential or intermittent disease. Hence, it require a proper analysis of
Cytomegalovirus Diagnostics Market to Record Ascending Growth by 2020
Cytomegalovirus belongs to the herpesviridae family and is a double-stranded DNA virus. This virus mainly causes asymptomatic infections or sometimes causes mild flu like symptoms; and later remains latent throughout life, which may reactivate. Thus, this virus can remain as a lifelong companion for some individuals and can be a silent killer for the others. Cytomegalovirus (CMV) infection is characterized by the development of such antibodies, which develop due to
Global Cytomegalovirus Retinitis Market Size, Share | MarketResearchReports.biz
Latest industry research report on: Global Cytomegalovirus Retinitis Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Cytomegalovirus (CMV) Retinitis is caused by cytomegalovirus infection, which is a herpes-type virus that affects the retina of the human eye among patients having a weak immune system that could be due to conditions such as AIDS, leukemia and/or pregnancy. Symptomatic conditions include floaters, flashes, and blind spots besides
Human Papillomavirus and Cytomegalovirus Therapeutics Market Analysis & Trends 2 …
A report by Transparency Market Research forecasts the global human papillomavirus (HPV) therapeutics market to rise at a CAGR of 7.7% during the period between 2014 and 2020 to become worth US$2.34 bn by 2020 from US$1.40 bn in 2012. According to the report, the global cytomegalovirus (CMV) market will rise at a 1.49 % CAGR from 2014 to 2020 to attain a value of US$922.8 mn by 2020 from
Human Papillomavirus and Cytomegalovirus Therapeutics Market Growth Analysis 202 …
Some of the prominent names in The Global Human Papillomavirus (HPV) And Cytomegalovirus (CMV) Therapeutics Market are Valeant Pharmaceuticals, Roche AG, Perrigo Company plc, Fougera Pharmaceuticals, Clinigen Group plc., and Fresenius Kabi USA. Of them, Valeant Pharmaceuticals accounts for a leading share in the HPV therapeutics market and Roche AG accounts for a dominant share in the CMV therapeutics market. A report by Transparency Market Research forecasts the global human papillomavirus